$MCHX

Marchex (MCHX) Reports Q1 Loss, Misses Revenue Estimates

Marchex (MCHX) delivered earnings and revenue surprises of -100% and 4.35%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Original reporting
Zacks Commentary · Zacks Equity Research
Published May 13, 2025, 9:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 14, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Marchex (MCHX) Reports Q1 Loss, Misses Revenue Estimates — source image
Decision brief

The 30-second read

$MCHXBearishMed
01

Why it matters

The earnings miss may lead to short-term selling pressure, but revenue growth suggests underlying demand remains.

02

Market read

The news is relevant for traders with exposure to MCHX or the tech sector; other stocks are less affected.

03

What to watch

Potential for company to implement cost-cutting measures or strategic pivots that could improve future performance.

Timing: short-term (next 1-2 weeks)

Background

Marchex reported Q1 2025 earnings with a significant loss, possibly due to operational issues or one-time charges.

Company-level read

Ticker impact

$MCHXBearishMedium confidence
Context

The company's recent quarterly earnings report indicates a significant loss and a slight revenue beat, which may influence short-term trading decisions.

Expected impact

Potential short-term decline due to earnings miss, but limited long-term impact if revenue growth sustains.

Evidence & confidence

The earnings miss is severe, but revenue growth and low relevance sentiment suggest limited immediate downside; technical levels and broader market conditions should be monitored.

Market effects

Technology sector may experience slight volatility due to earnings reports from individual companies.

Limited regional impact; primarily affects US-based stocks.

Negligible; company-specific news with limited global implications.

Counterpoint

The revenue increase, though modest, could signal resilience, and the stock might rebound if market perceives the loss as a one-time event.

Key entities

  • Marchex

    A provider of call tracking and analytics solutions.

Related articles

$MCHXMed

MARCHEX INC (MCHX): Results of Operations and Financial Condition

MARCHEX INC (MCHX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mchx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Marchex Announces Second Quarter 2026 Financial Results Reports Improved Profitability and Early Momentum Following Archenia Acquisition SEATTLE, WA – August 12, 2026 – Marchex, Inc. (NASDAQ: MCHX), a vertically focused, AI-d

$NOCHighAI 9/10

Northrop Grumman wins $216M radar contract expansion

Northrop Grumman (NOC) received a $215.9M contract modification from the U.S. Department of War for its Deep Space Advanced Radar Capability program. The total contract value increased to $495.4M. Work will be completed by March 2030 at the company's Colorado Springs facility, with $51.4M in fiscal 2025 funds obligated at the time of award.